Status:
COMPLETED
Zilver Flex Post-Market Study in Japan
Lead Sponsor:
Cook Group Incorporated
Conditions:
Peripheral Arterial Disease (PAD)
Eligibility:
All Genders
Phase:
NA
Brief Summary
Japanese post market clinical study of the Zilver Flex device.
Eligibility Criteria
Inclusion
- Symptomatic peripheral arterial disease (PAD) involving the above-the-knee femoropopliteal arteries
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 26 2017
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT02254356
Start Date
May 1 2012
End Date
December 26 2017
Last Update
March 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fukuoka Sanno Hospital
Fukuoka, Japan, 814-0001